New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For JBL;ARRS;GOOG;NYX;ICE;SD;ACN;BBBY;FOLD;GSK;MDRX From The Last 14 Days
Check below for free stories on JBL;ARRS;GOOG;NYX;ICE;SD;ACN;BBBY;FOLD;GSK;MDRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
April 24, 2014
19:05 EDTGOOGFour tech companies agree to settle wage lawsuit, WSJ says
Subscribe for More Information
17:35 EDTGOOGGoogle senior VP Vic Gundrota to leave company
Subscribe for More Information
15:20 EDTGOOGEarnings Preview: Microsoft to report for first time with Nadella at helm
Subscribe for More Information
13:24 EDTGOOGGoogle+ chief Vic Gundotra to depart the company, Re/code reports
Vic Gundotra, the head of Google+, is leaving the company, Re/code reports, citing a company spokesperson and an internal memo from Google CEO Larry Page. Gundotra's departure is immediate. Page says the company will continue to invest in Google+, and sources say he has picked David Bresbis to replace Gundotra. Reference Link
05:56 EDTSDStocks with implied volatility movement; CHK SD
Stocks with implied volatility movement; Chesapeake (CHK) 33, SandRidge Energy (SD) 44 according to iVolatility.
April 23, 2014
13:29 EDTGSKArray BioPharma: Novartis to honor Array-Novartis agreement with binimetinib
Subscribe for More Information
10:01 EDTGSKOn The Fly: Analyst Upgrade Summary
A.O. Smith (AOS) upgraded at BMO Capital... Agnico-Eagle (AEM) upgraded to Outperform from Sector Perform at RBC Capital... Allergan (AGN) upgraded to Overweight from Neutral at JPMorgan... Cabot Oil & Gas (COG) upgraded to Buy from Hold at Societe Generale... Cree (CREE) upgraded to Buy from Hold at Summit Research... E-Trade (ETFC) upgraded to Outperform from Market Perform at Wells Fargo... Equifax (EFX) upgraded at Credit Suisse... Fluidigm (FLDM) upgraded to Buy from Neutral at Mizuho... GlaxoSmithKline (GSK) upgraded to Buy from Hold at Argus... GulfMark Offshore (GLF) upgraded to Buy from Neutral at Global Hunter... Hanmi Financial (HAFC) upgraded to Outperform from Market Perform at Fig Partners... Illumina (ILMN) upgraded to Buy from Hold at Maxim... Lumber Liquidators (LL) upgraded to Buy from Neutral at Longbow... Medidata Solutions (MDSO) upgraded to Buy from Neutral at B. Riley... Prologis (PLD) upgraded to Buy from Neutral at ISI Group... Sanmina (SANM) upgraded to Buy from Hold at Craig-Hallum... SunPower (SPWR) upgraded to Buy from Hold at Deutsche Bank... TECO Energy (TE) upgraded to Neutral from Sell at UBS... Torchmark (TMK) assumed with a Market Perform from Underperform at Keefe Bruyette... Valeant (VRX) upgraded to Buy from Hold at TD Securities... Vitamin Shoppe (VSI) upgraded at Sterne Agee... Wolseley (WOSYY) upgraded to Outperform from Neutral at Credit Suisse... athenahealth (ATHN) upgraded to Overweight from Equal Weight at Morgan Stanley.
08:34 EDTGOOGGoogle and SunPower partner to finance $250M in residential solar lease projects
Subscribe for More Information
08:10 EDTGOOGGoogle took on some Samsung liability in fight with Apple, Re/code says
Subscribe for More Information
07:24 EDTGSKGlaxoSmithKline upgraded to Buy from Hold at Argus
Subscribe for More Information
07:00 EDTFOLDTerrapinn to hold a conference
Subscribe for More Information
06:54 EDTGSKCambridge Healthtech Institute to hold a conference
Subscribe for More Information
06:28 EDTGOOGGoogle ads to link inside mobile apps
Google says it will allow advertisers to direct smartphone users directly to apps installed on their devices. Reference Link
06:16 EDTGSKPharmaceutical companies narrowing focus, WSJ reports
Subscribe for More Information
April 22, 2014
16:33 EDTGSKOn The Fly: Closing Wrap
Subscribe for More Information
16:04 EDTGOOGOptions Update; April 22, 2014
Subscribe for More Information
13:18 EDTGOOGOpera says Android overtook iOS in mobile ad traffic
Subscribe for More Information
13:07 EDTGOOGYouTube's head of product leaving company, Re/code reports
Subscribe for More Information
12:39 EDTGSKOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday amid a number of big deals and a much talked about proposed deal in the pharmaceutical industry, as well as another wave of earnings reports. The market opened quietly but on the positive side of the ledger as investors pored over the multitude of quarterly reports issued after the close last night and earlier today. Near noon the market stood near its session highs and is pointing toward its sixth consecutive positive close. ECONOMIC EVENTS: In the U.S., existing home sales slipped 0.2% to a 4.59M rate in March, versus expectation for them to have fallen 1% to a 4.56M rate. The Richmond Fed manufacturing survey for April had a reading of 7, beating the consensus forecast for a reading of 2. COMPANY NEWS: Valeant Pharmaceuticals (VRX) teamed with Bill Ackman's hedge fund Pershing Square to make a hostile takeover offer for Allergan (AGN), sending shares of both companies higher. Allergan confirmed it received the offer of $48.30 in cash and 0.83 shares of Valeant stock for each of its own shares, which it said it will evaluate with the help of its advisers. Analysts' opinion on the fallout varied, with one firm suggesting Allergan could pursue its own takeover of Shire (SHPG) or Jazz Pharmaceuticals (JAZZ) as a defense, and another saying a rival big pharma company, such as Johnson & Johnson (JNJ) or Merck (MRK), could launch a competing bid for Allergan. Shares of Allergan led all gainers on the S&P 500, rising 16%, while Valeant shares gained more than 6%... A number of other big drug makers made news with a string of deals, as Novartis (NVS) and GlaxoSmithKline (GSK) both reshaped their companies via a trio of agreements. Novartis will acquire GSK's oncology products for a $14.5B payment and up to $1.5B contingent future payments, Novartis will sells its Vaccines business, excluding flu, to GSK for $7.1B plus royalties, and the two agreed to tie-up their consumer healthcare businesses through a joint venture. In a separate transaction, Novartis agreed to divest its Animal Health Division to Eli Lilly (LLY) for about $5.4B. MAJOR MOVERS: Among the notable gainers following their earnings reports were streaming video service Netflix (NFLX), which advanced almost 6%, and motorcycle maker Harley-Davidson (HOG), which rose 8%. Companies that slid following their earnings reports included printer maker Lexmark (LXK), which fell over 11%, and Pentair (PNR), which dropped almost 6%. INDEXES: Near midday, the Dow was up 106.77, or 0.65%, to 16,556.02, the Nasdaq was up 45.95, or 1.11%, to 4,167.50, and the S&P 500 was up 11.59, or 0.62%, to 1,883.48.
09:16 EDTGSKOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Netflix (NFLX), up 8%... Harley-Davidson (HOG), up 7%... PLX Technology (PLXT), up 8%... Illinois Tool (ITW), up 2.3%... Comcast (CMCSA), up 1%... McDonald's (MCD), up 0.6%. ALSO HIGHER: Allergan (AGN), up 17% after Valeant (VRX) confirms proposal to combine with the company for $48.30 and 0.83 shares of stock. Valeant is up 5% following its confirmation of the news that broke last night... GlaxoSmithKline (GSK), up 4.5% after agreeing to sell oncology products for $14.5B to Novartis (NVS) and buy Novartis' Vaccines business, currently excluding its flu business, for $7.1B plus royalties. Novartis shares trading in New York are also up 1% following the deals... Revance Therapeutics (RVNC), up 20% after announcing positive results from RT002 Phase 1/2 study... Facebook (FB), up 2% following upgrade at Credit Suisse. DOWN AFTER EARNINGS: Xerox (XRX), down 4%... Lexmark (LXK), down 4.8%. ALSO LOWER: Allison Transmission (ALSN), down 4% after filing to sell 25M shares for holders... FireEye (FEYE), down 2.9% after filing to sell 13.3M shares of common stock for holders... Bebe stores (BEBE), down 16% after reporting preliminary Q3 losses that were steeper than the consensus estimate.
08:51 EDTBBBYBed Bath & Beyond settles with NY AG over hiring practices
Subscribe for More Information
08:49 EDTGSKGSK, Theravance announce Phase III study of FF/VI in Japan
Subscribe for More Information
08:37 EDTGSKTheravance, GlaxoSmithKline receive Australian approval for Breo Ellipta
GlaxoSmithKline (GSK) and Theravance (THRX) announced that the Therapeutic Goods Administration has approved BREO ELLIPTA for the treatment of patients with asthma or chronic obstructive pulmonary disease, or COPD, in Australia. Two strengths of BREO ELLIPTA have been licensed for the treatment of asthma and one strength has been licensed for the treatment of COPD.
07:48 EDTGSKGlaxoSmithKline to host conference call
Subscribe for More Information
07:46 EDTGSKGlaxo thinks Novartis agreement could mean future disposals, Reuters says
Subscribe for More Information
06:37 EDTGOOGCompanies with cloud businesses worried about Aereo case, Re/code says
Subscribe for More Information
05:35 EDTGSKNovartis says transactions 'represent a transformation' for the company
The elements of the transaction with GSK (GSK) are inter-conditional and subject to approval by GSK shareholders. The Novartis (NVS) board unanimously believes that the transactions with GSK and the transaction with Lilly (LLY) are in the best interests of Novartis and the Novartis Shareholders as a whole. The transaction with Lilly is expected to close by the end of 1Q15 and the transaction with GSK is expected to close during the first half of 2015. The terms of the divestment of the Vaccines business would maximize the value of its pipeline, including Bexsero. The divestment of Animal Health would recognize the full value of the business. The transactions are expected to improve Novartis' sales and core operating income growth rates, while improving margins. Each of the transactions is projected to be value creating. The company commented, "These transactions represent a transformation for Novartis. We have leading positions in our core businesses in high-growth segments of healthcare. This will enable us to continue to build the world's most respected and successful healthcare company. Our strategic focus on science-based innovation and our global scale position the company well to meet the changes in the healthcare industry for the coming decade and beyond."
05:26 EDTGSKNovartis OTC, GSK Consumer Healthcare form joint venture
Subscribe for More Information
05:23 EDTGSKNovartis divests Vaccines business to GSK for $7.1B
Novartis (NVS) has agreed to divest its Vaccines business to GSK (GSK), currently excluding its flu business, for $7.1B plus royalties. The $7.1B consists of $5.25B upfront and up to $1.8B in milestones. As a part of a value-maximization strategy in the context of the portfolio review, Novartis has initiated a separate sales process for its flu business.
05:20 EDTGSKNovartis to acquire GSK oncology products for $14.5B
Subscribe for More Information
April 21, 2014
13:36 EDTGOOGGoogle wants to add encryption tools to Gmail, VentureBeat says
Subscribe for More Information
10:49 EDTGOOGOptions with decreasing implied volatility: SRPT NSR INFY CMG GOOG
Subscribe for More Information
10:01 EDTJBLOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:32 EDTJBLJabil Circuit downgraded at RBC Capital
As noted earlier, RBC Capital downgraded Jabil Circuit (JBL) to Sector Perform from Outperform. As reasons for the downgrade, the firm cited concerns about Jabil circuit's largest customer, Apple (AAPL), as well as its belief that Jabil's FY15 guidance appears to reflect a best-case scenario. Target to $20 from $21.
06:51 EDTICENYSE, BofA among those sued regarding high-frequency trading, Bloomberg says
Subscribe for More Information
06:48 EDTGOOGMicrosoft faces internal & external conflicts in three segments, DigiTimes says
Subscribe for More Information
06:45 EDTGOOGApple and Google compete to offer exclusive game apps, WSJ reports
Subscribe for More Information
06:41 EDTGOOGGoogle to partner with HTC for 8-inch Nexus, DigiTimes reports
Subscribe for More Information
06:37 EDTGOOGSquare discusses possible sale as losses widen, WSJ reports
Mobile-payments startup Square discussed a possible sale to several rivals as its losses widen, reports the Wall Street Journal, citing people familiar with the matter. Google (GOOG) discussed a possible acquisition of the company earlier this year, but it was not clear if the talks were continuing. Square also had discussions about a deal with Apple (AAPL) and eBay's (EBAY) PayPal. Reference Link
06:26 EDTGOOGCourt documents say Silicon Valley giants discussed hiring, WSJ says
Google (GOOG), Apple (AAPL), Intel (INTC) and Adobe (ADBE had colluded with one another to supress wages between 2005 and 2009, reports the Wall Street Journal, citing documents from an antitrust case. The companies had agreed not to poach each other's employees among other things. The companies had also tried to bring Facebook (FB) on board, but Facebook rejected the offer. Reference Link
06:17 EDTJBLJabil Circuit downgraded to Sector Perform from Outperform at RBC Capital
Subscribe for More Information
April 19, 2014
20:17 EDTGOOGTwitter, Netflix, Amazon look pricey, Barron's says
Subscribe for More Information
April 18, 2014
09:44 EDTARRSARRIS acquires Ontario-based SeaWell Networks
ARRIS announced it acquired Mississauga, Ontario-based SeaWell Networks for an undisclosed amount. ARRIS is integrating SeaWell's adaptive bit rate streaming technologies and talent into its Network & Cloud business.
April 17, 2014
16:45 EDTGOOGMarket swings to gains in holiday-shortened week
Subscribe for More Information
16:31 EDTGOOGOn The Fly: Closing Wrap
Subscribe for More Information
15:55 EDTGSKGlaxoSmithKline, Genmab get FDA approval for Arzerra use
GlaxoSmithKline (GSK) and Genmab (GNMSF) announced that the U.S. FDA has approved a Supplemental Biologic License Application for the use of Arzerra, a CD20-directed monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukemia for whom fludarabine-based therapy is considered inappropriate. The FDA approval of the first-line indication is based on results from a Phase III study which demonstrated statistically significant improvement in median progression-free survival in patients who received the combination of ofatumumab and chlorambucil compared to patients who received chlorambucil alone.
15:03 EDTGSKFDA grants wider approval for Glaxo's Arzerra in treatment of CLL
Subscribe for More Information
12:53 EDTGOOGOn The Fly: Midday Wrap
Subscribe for More Information
11:43 EDTGSKGlaxoSmithKline announces Canadian approval for Incruse Ellipta
GlaxoSmithKline announced that Incruse Ellipta has received market authorization in Canada for the long-term once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, or COPD, including chronic bronchitis and emphysema. This is the first market authorization granted for this product anywhere in the world, the company noted.
10:11 EDTGOOGHigh option volume stocks: CMG INFY GOOGL GOOG SNDK MAT YHOO BX KSU GILD
Subscribe for More Information
09:35 EDTGOOGActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GOOGL GOOG NFLX TSLA AMZN GOLG NOV AA IBM
09:09 EDTGOOGGoogle price target lowered to $670 from $710 at RBC Capital
Subscribe for More Information
08:58 EDTGOOGOn The Fly: Pre-market movers
Subscribe for More Information
08:45 EDTGOOGThe Cato Institute to hold a discussion
Subscribe for More Information
08:18 EDTGOOGGoogle capex expansion positive for Finisar, Juniper, says Janney Capital
Subscribe for More Information
08:12 EDTGOOGGoogle price target lowered to $660 from $690 at BofA/Merrill
Subscribe for More Information
07:24 EDTGOOGFutures lower as earnings disappoint
U.S. equity futures are lower following disappointing earnings reports from tech giants IBM (IBM) and Google (GOOG). Earnings will be taking center stage for the next few weeks Meanwhile, investors will continue to analyze economic data. Expected to be released today are weekly jobless claims data and the natural gas inventory report.
07:20 EDTGSKGlaxoSmithKline opens internal probe of bribery allegations, WSJ says
Subscribe for More Information
06:51 EDTGOOGGoogle shares still compelling, says Cantor
Subscribe for More Information
05:56 EDTGOOGGoogle price target lowered to $625 from $665 at Deutsche Bank
Deutsche Bank lowered its price target for Google shares to $625 following the company's Q1 results but it continues to view the stock as a top idea. The firm views the results as in-line and it keeps a Buy rating on Google.
05:49 EDTGOOGGoogle price target raised to $735 from $725 at Credit Suisse
Credit Suisse raised its price target for Google shares to $735 and reiterates an Outperform rating on the stock following the company's Q1 results. Credit Suisse views the results as mixed, but says the most important takeaway was the positive inflection in the CPC decline rate.
April 16, 2014
18:55 EDTGOOGOn The Fly: After Hours Movers
Subscribe for More Information
17:57 EDTGOOGYahoo seeks default search status for Apple products, Re/code says
Subscribe for More Information
16:42 EDTGOOGGoogle says Moto G showed 'strong sales momentum' in emerging markets
Comment made on company's Q1 earnings webcast.
16:40 EDTGOOGOn The Fly: Closing Wrap
Stocks on Wall Street were higher after Fed Chair Janet Yellen struck a dovish tone in comments to the Economic Club of New York, which was in step with the minutes of the last FOMC meeting released last week. The Fed also released its latest Beige Book report, which indicated that economic activity increased in most regions after the severe winter weather that gripped much of the country to start the year had let up. Corporate earnings season continues to pick up steam, with Dow members IBM (IBM) and American Express (AXP), as well as Google (GOOG), reporting after the market close. ECONOMIC EVENTS: In the U.S., housing starts in March were up 2.8% from the prior month to a rate of 946K, versus expectations for an increase of 7%. Building permits were down 2.4% to a 990K rate, versus expectations for a decline of 0.4%. Industrial production rose 0.7% in March, which was ahead of the 0.5% forecast. The Fed's Beige Book report indicated that economic activity rebounded and strengthened in most regions over the last six week. In China, data showed its economy grew 7.4% in the first quarter from a year earlier, providing relief after recent signs that growth in the world's second largest economy has been slowing. COMPANY NEWS: Bank of America (BAC) fell 26c, or 1.59%, to $16.13 after the bank reported a first quarter loss of 5c per share, largely due to $6B in legal charges. Excluding the impact of this litigation expense, which was related to a previously announced settlement with the Federal Housing Finance Agency and other legacy mortgage-related matters, the banking major reported earnings that appeared to beat estimates... Yahoo (YHOO) gained $2.14, or 6.26%, to $36.35 after its quarterly report, with investors reacting most positively to the 66% year-over-year revenue growth reported by Chinese e-commerce company Alibaba, in which Yahoo holds a 24% stake. Yahoo's quarterly profit and revenue also beat expectations and the company's CEO Marissa Mayer said during its earnings webcast that the search giant's core business has moved from declining growth to stable to modest growth. MAJOR MOVERS: Among the notable gainers was CBS Outdoor (CBSO), which jumped $1.94, or 6.69%, to $30.96 after the IRS approved a plan for the company, which was just last week spun-off from its parent CBS (CBS), to convert into a real estate investment trust, or REIT. Other companies seeking REIT status, including Equinix (EQIX), Iron Mountain (IRM) and Lamar Advertising (LAMR), also rose following CBS' announcement. Also higher was drugmaker Zogenix (ZGNX), up 48c, or 20.51%, to $2.82 after confirming that a judge prevented a ban on sales of the company's Zohydro pain medication in Massachusetts. Among the noteworthy losers were U.S.-listed shares of Credit Suisse (CS), which fell 54c, or 1.7%, to $31.22 after the Swiss bank reported net income and revenue that fell when compared to the prior year. Also lower were Agnico Eagle Mines (AEM) and Yamana Gold (AUY) after agreeing to jointly acquire Osisko Mining. Angico shares fell $2.61, or 8.56%, to $27.88, while Yamana was down 36c, or 4.3%, to $8.02. INDEXES: The Dow was up 162.29, or 1.0%, to 16,424.85, the Nasdaq was up 52.06, or 1.29%, to 4,086.23, and the S&P 500 was up 19.33, or 1.05%, to 1,862.31.
16:06 EDTGOOGGoogle down more than 5% after missing on top and bottom lines
Subscribe for More Information
16:06 EDTGOOGGoogle says expects to continue to make 'significant capital expenditures'
Reports net cash provided by operating activities in Q1 totaled $4.39B, compared to $3.63B in the prior year period. In Q1, capital expenditures were $2.35B, the majority of which was for production equipment, data-center construction, and real estate purchases. Free cash flow in Q1 was $2.05B.
16:04 EDTGOOGGoogle reports Q1 average cost-per-click down 9%
Reports paid click up 26%. Reports traffic acquisition costs increased to $3.23B vs $2.96B for the prior year period.
16:03 EDTGOOGGoogle reports Q1 sites revenue up 21% to $10.47B
Reports Q1 network revenues up 4% to 3.4B.
16:03 EDTGOOGGoogle reports Q1 EPS $6.27, consensus $6.40
Subscribe for More Information
15:17 EDTGOOGNotable companies reporting after market close
Subscribe for More Information
14:54 EDTGOOGGoogle April 550 straddle priced for 5.3% move into Q1
Subscribe for More Information
10:45 EDTBBBYOptions with decreasing implied volatility: BBBY INFY RAD FDO
Subscribe for More Information
09:03 EDTMDRXAllscripts should see core business stability, says RW Baird
Baird said recent restructuring actions and strong bookings at Allscripts will lead to predictable P&L performance and help narrow its valuation discount to its peers. The firm maintains an Outperform rating and $23 price target on Allscripts.
07:41 EDTICEICE owner purchases Algo Technologies, Bloomberg says
The new owner of IntercontinentalExchange has been exploring matching engine software and purchased Algo Technologies in response to that, according to Bloomberg, citing two people familiar with the matter. The sources said that Algo Technologies is a firm that claims to have the industry’s quickest matching engine. Reference Link
07:40 EDTGOOGGoogle Play Q1 downloads exceeded downloads from Apple store, App Annie says
Subscribe for More Information
07:07 EDTGOOGAmazon, Google, Microsoft cut prices for cloud computing products, WSJ says
Subscribe for More Information
06:52 EDTGOOGSamsung objects to Apple's patent claims in $2B court battle, Bloomberg says
Subscribe for More Information
06:50 EDTGOOGGoogle could be working on smart contact lenses, Business Insider says
Subscribe for More Information
06:08 EDTGOOGGoogle seeking third-party developers for 'modular' project, WSJ reports
Subscribe for More Information
April 15, 2014
14:29 EDTGSKGlaxoSmithKline confirms FDA approval for Tanzeum
Subscribe for More Information
13:18 EDTGOOGDaniel Graf to join Twitter's product team
Daniel Graf, who led efforts on Google Maps (GOOG), is joining Twitter's (TWTR) product team, Graf announced in a tweet. Reference Link
12:45 EDTGOOGEarnings Preview: Google shares down 8% since last earnings report
Google (GOOG, GOOGL) is expected to report first quarter earnings after the market close on Wednesday, April 16 with a conference call scheduled for 4:30 pm ET. Google is a global technology company that focuses on Internet search, cloud computing, and advertising technologies. EXPECTATIONS: Analysts are looking for earnings per share of $6.39 on revenue of $15.52B. The consensus range is $5.83-$6.96 for EPS, and $14.94B-$16.12B for revenue, according to First Call. LAST QUARTER: Google reported Q4 EPS $12.01 against estimates of $12.26 on revenue of $16.86B against estimates of $16.75B. Google reported Q4 paid clicks up 31% and average cost-per-click decreased approximately 11%. The company also reported Q4 Sites revenue $10.55B and Q4 Network revenue $3.52B. NEWS: Google effectively split its stock with a dividend distribution of Class C shares, which began trading in early April. In the past quarter, the company reached a deal with a European Union after sending an improved commitments proposal in context of the ongoing antitrust investigation on online search and search advertising. Google also announced that it resolved the copyright litigation with Viacom (VIA, VIAB). The company announced partnerships and agreements with VMware (VMW), Cisco (CSCO), and OmniVision (OVTI) as well as acquisitions of SlickLogin, Titan Aerospace and parts of Green Throttle Games. STREET RESEARCH: Cantor said Google is being boosted by product listing ads, which are expected to increase the company's 2014 ad revenue by $1B. Atlantic Equities and Bernstein said Google's weakness provides a buying opportunity, citing strong year-over-year revenue growth at "core Google." Bernstein added predictions that Google Play, Computer and App Engine, and Apps for Enterprise and government will become multi-billion dollar businesses. Ahead of the Q1 earnings, Susquehanna said the results should beat expectations due to continued website growth, PLAs, and early benefits from Enhanced Campaigns and YouTube. PRICE ACTION: Google shares have dropped over 8% since the first day of trading following the company's Q4 report. In Tuesday midday trading ahead of Q1 report, Google shares are down a little over 2%.
11:23 EDTACNInfosys falls after quarterly revenue trails estimates
Shares of Infosys (INFY), which consults on business information technology and systems integration, are falling after the company's fourth quarter revenue trailed analysts' consensus estimate. WHAT'S NEW: This morning, Infosys reported fourth quarter earnings per share of 85c and revenue of $2.09B, compared to expectations of 79c and $2.11B, respectively. The company's CEO and Managing Director, S. D. Shibulal, said he was pleased that Infosys was able to double its growth rate for the full year compared to last year, though added that its performance in the last quarter of of the fiscal year had been "disappointing." The company noted that Infosys and its subsidiaries added 50 clients during the quarter and 238 during the year. Infosys forecast FY15 revenue growth of 7%-9%, compared to consensus of $9.06B. WHAT'S NOTABLE: Infosys said its board had decided to increase the dividend pay-out ratio to up to 40% of post-tax profits effective FY14. Infosys' current policy is to pay dividends up to 30% of post-tax profits. OTHERS TO WATCH: Like Infosys, Wipro (WIT) is an IT services and software solution consultant headquartered in India. Others in the business consulting space include Cognizant Technology (CTSH), IBM (IBM) and Accenture (ACN). PRICE ACTION: In late morning trading, Infosys fell $3.49, or about 6.3%, to $52.09 on nearly twice its average daily trading volume. Shares of Cognizant were down about 0.75% to $48.12, while Wipro was up about 2.6% to $13.56.
10:18 EDTBBBYOptions with decreasing implied volatility: BBBY INFY STZ RAD
Subscribe for More Information
10:14 EDTGSKFDA approves Tanzeum to treat type 2 diabetes
The Food and Drug Administration approved Tanzeum subcutaneous injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes. Tanzeum has a Boxed Warning to warn that tumors of the thyroid gland have been observed in rodent studies with some GLP-1 receptor agonists, but that it is unknown whether Tanzeum causes thyroid C-cell tumors, including a type of thyroid cancer called medullary thyroid carcinoma, in humans. Tanzeum should not be used in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2. The FDA approved Tanzeum with a Risk Evaluation and Mitigation Strategy, which consists of a communication plan to inform health care providers about the serious risks associated with Tanzeum. Tanzeum is manufactured by GlaxoSmithKline.
10:00 EDTMDRXOn The Fly: Analyst Initiation Summary
Allscripts (MDRX) reinstated with an Outperform at Raymond James... Amber Road (AMBR) initiated with a Buy at Canaccord... Autonation (AN) coverage assumed with a Market Perform at Wells Fargo... BG Group (BRGYY) initiated with an Outperform at BMO Capital... Borderfree (BRDR) initiated with a Buy at Canaccord... Dean Foods (DF) initiated with a Buy at BB&T... Destination XL (DXLG) initiated with a Buy at Ascendiant... Group 1 Automotive (GPI) coverage assumed with a Market Perform at Wells Fargo... Halozyme (HALO) initiated with a Buy at Citigroup... MakeMyTrip (MMYT) initiated with a Neutral at Goldman... Penske Automotive (PAG) coverage assumed with a Market Perform at Wells Fargo... RPM (RPM) initiated with an Outperform at Wells Fargo... RSP Permian (RSPP) initiated with a Buy at KLR Group... Repligen (RGEN) initiated with a Buy at Jefferies... Spansion (CODE) initiated with a Buy at Sterne Agee... Statoil (STO) initiated with a Market Perform at BMO Capital... TPG Specialty Lending (TSLX) initiated with a Buy at BofA/Merrill... Versartis (VSAR) initiated with a Buy at Citigroup... WWE (WWE) initiated with a Buy at Needham... WebMD (WBMD) reinstated with a Strong Buy at Raymond James.
08:39 EDTGOOGNetlist patent with LRDIMM claims confirmed in reexamination
Subscribe for More Information
08:23 EDTGSKLeerink's pharma and biotech analysts hold an analyst/industry conference call
Subscribe for More Information
08:20 EDTGOOGAeroVironment has limited comparability to Google acquisition, says CRT Capital
Subscribe for More Information
08:06 EDTGSKProsonix, Mylan enter licensing deal for generic version of Flixotide, Flovent
Subscribe for More Information
07:28 EDTICESEC officials weighing curbs on trading fees, WSJ says
SEC officials, including some commissioners, are considering a trial program to curb "maker-taker" fee plans that are a major source of revenue for exchanges and some high-frequency trading firms, according to The Wall Street Journal. Fund managers, including BlackRock (BLK), are concerned about the negative effects of maker-taker, the report added. IntercontinentalExchange (ICE) CEO Jeffrey Sprecher, along with representatives from T. Rowe Price (TROW) and from RBC Capital (RY), recently held a series of private meetings with SEC Chairman Mary Jo White to push for its elimination, according to the report, citing people familiar with the matter. Like IntercontinentalExchange, which owns the New York Stock Exchange, Nasdaq (NDAQ) is a publicly-traded exchange operator. Reference Link
07:11 EDTGOOGLattice FPGAs selected by Google ATAP Group for Project Ara smartphone prototype
Subscribe for More Information
06:46 EDTGOOGGoogle price target raised to $700 from $650 at Jefferies
Jefferies raised its price target for Google shares to $700 ahead of the company's Q1 results on Wednesday and it keeps a Buy rating on the stock. The new price target reflects the sale of Motorola. Jefferies notes its survey indicates Google's traffic trends were solid in Q1.
06:38 EDTGOOGGoogle to use satellites to take photos, expand use of Internet, NY Times says
Google said that it would use Titan Aerospace's drone satellites to take photos of the Earth and connect people to the Internet, according to The New York Times. Google announced yesterday that it would buy Titan. Reference Link
06:32 EDTGSKPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link
06:02 EDTGOOGGoogle Glass goes on sale to U.S. residents today, USA Today reports
Beginning at 9 am ET, Google Glass will be available for U.S. residents for $1,500 plus tax, USA Today reports. This one-day sale is an expansion of the company's 2012 Glass Explorer program. Reference Link
April 14, 2014
16:51 EDTMDRXAllscripts reinstated with an Outperform at Raymond James
Subscribe for More Information
14:06 EDTGOOGGoogle to acquire Titan Aerospace, WSJ says
Subscribe for More Information
13:32 EDTGOOGGoogle April volatility elevated at 68 into Q1 and revenue outlook
Subscribe for More Information
12:01 EDTICEIntercontinentalExchange sets new daily record for ICE NYH RBOB futures
Subscribe for More Information
10:58 EDTBBBYOptions with decreasing implied volatility: BBBY FDO STZ RAD
07:06 EDTGOOGU.S. Geospatial Intelligence Foundation to hold a symposium
GEOINT 2013 Symposium, originally scheduled for October 2013, is being held in Tampa, Florida on April 14-17.
06:40 EDTGSKGlaxoSmithKline paid bribes to Polish doctors to promote Seretide, BBC says
Subscribe for More Information
06:11 EDTGOOGIntel works with HzO to enhance water resistance in products, DigiTimes says
Subscribe for More Information
April 13, 2014
20:11 EDTGOOGGoogle, Palo Alto, Cvent worth looking into, Barron's says
Subscribe for More Information
April 11, 2014
12:42 EDTBBBYOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:46 EDTBBBYOptions with decreasing implied volatility: MNKD QCOR NQ WWE BBBY
06:43 EDTGOOGGoogle enhancing Android security with apps checks, Re/code says
Subscribe for More Information
06:29 EDTGOOGGoogle says 'Jelly Bean' affected by Heartbleed
Subscribe for More Information
05:57 EDTGOOGCisco, Juniper say some products affected by Heartbleed bug, WSJ reports
Both Cisco (CSCO) and Juniper (JNPR) have disclosed that some of their products are affected by the Heartbleed bug, the Wall Street Journal reports. The companies say the security flaw affects routers, switches and firewalls used by businesses. Reference Link
April 10, 2014
16:34 EDTBBBYBed Bath & Beyond downgraded to Neutral from Buy at Citigroup
Citigroup downgraded Bed Bath & Beyond citing the company's disappointing FY15 outlook. Citi lowered its price target for shares to $72 from $85.
13:58 EDTGOOGGoogle to let any U.S. resident buy Google Glass, The Verge says
Subscribe for More Information
13:43 EDTICEFidelity to pitch new lost cost trading venue to large asset managers, WSJ says
Fidelity is working on a new trading venue, dubbed "Sakura," that it hopes will be a collaboration among big mutual-fund firms to reduce costs and streamline trading and will be an improvement over other "dark pools," reported The Wall Street Journal, citing people with knowledge of the matter. The report said Fidelity is in the initial planning stages and has just started pitching the idea to other large asset managers. Publicly traded fund managers include BlackRock (BLK), Franklin Resources (BEN) and T. Rowe Price (TROW), while Investment Technology Group (ITG) currently operates dark pools that facilitate block trading among large institutions. Exchange operators Nasdaq (NDAQ) and Intercontinentalexchange's (ICE) NYSE have previously testified to legislators that too much trading occurs in dark pools, hurting investors. Reference Link
12:25 EDTBBBYOn The Fly: Midday Wrap
Subscribe for More Information
11:47 EDTBBBYBed Bath & Beyond approaches 52-week low after profit forecast disappoints
Subscribe for More Information
11:42 EDTGSKReport claims Tamiflu, Relenza do little to prevent the spread of flu
Subscribe for More Information
11:15 EDTBBBYOptions with decreasing implied volatility: YONG STZ BBBY FDO EPB
10:00 EDTBBBYOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:21 EDTBBBYOn The Fly: Pre-market Movers
Subscribe for More Information
09:00 EDTBBBYBed Bath & Beyond falls 5%
Subscribe for More Information
07:43 EDTBBBYBed Bath & Beyond price target lowered to $75 from $80 at Argus
Subscribe for More Information
07:15 EDTBBBYBed Bath & Beyond price target lowererd to $70 from $78 at Credit Suisse
Credit Suisse lowered Bed Bath & Beyond 's estimates due to slower than expected buybacks and a lower growth rated. Shares are Neutral rated.
06:49 EDTGOOGMotorola Mobility names Osterloh COO
Subscribe for More Information
06:29 EDTGOOGAT&T in talks to bring ultrafast internet to North Carolina, WSJ reports
Subscribe for More Information
05:49 EDTBBBYBed Bath & Beyond downgraded to Neutral from Buy at BofA/Merrill
Subscribe for More Information
05:40 EDTACNAccenture, SAP expand global alliance through first-of-its-kind agreement
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use